Schroders will offer a 2% initial charge discount on unit trust investments in its Medical Discovery...
Schroders will offer a 2% initial charge discount on unit trust investments in its Medical Discovery and EuroTech funds to be launched next month, writes Leo Bland.
The discounts will take the initial charge on both funds to 3.25% on unit trust investments for a three-week period from the launch date of 22 May. Schroders will still pay up to 3% initial commission on unit trust investments during the offer period.
Schroder Medical Discovery will be run from New York and will invest in sectors including biotechnology, pharmaceuticals, medical technology and medical supply companies.
The fund, run by Kristine Bryan, will look to take advantage of medical advances from biotechnology companies as well as merger and acquisitions activity in the pharmaceuticals arena.
Schroder EuroTech, run by Michael Grant, will focus on pure technology companies as well as new and emerging industries where growth prospects have been enhanced by technology developments.
Tapered annual allowance headache
Our weekly heads-up for advisers
Acquisition completed earlier this month.
Changes to take place by next year
Launched 18 November